Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Verus International Inc (VRUS)

Verus International Inc (VRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 890 K
  • Annual Income, $ -91,180 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 0.00
  • Price/Book 66.95
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/06/12
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/11
See More
  • Average Estimate -0.36
  • Number of Estimates 8
  • High Estimate -0.30
  • Low Estimate -0.50
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -5.88%

Most Recent Stories

More News
Verus Sells Out First Flörd Production Run; Adds Ten States to Sales Footprint

Orlando, FL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS), a food and hemp-based products...

OTC.VN : 0.305 (unch)
VRUS : 0.0001 (unch)
Verus Signs 2nd Distribution Agreement in Florida; Announces Launch Date for Flörd Product Line

Orlando, FL, July 19, 2022 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS), a food and hemp-based products...

OTC.VN : 0.305 (unch)
VRUS : 0.0001 (unch)
Verus International Signs 3rd U.S. Distributor – Provides CEO Update

Gaithersburg, MD, July 12, 2021 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS), an international food, CBD and hemp-based products company, is pleased...

VRUS : 0.0001 (unch)
Verus International Reports Fiscal 2021 Q2 Financial Results; Posts Significant Improvement in Gross Profit Margins

Gaithersburg, MD, June 22, 2021 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS), an international food, CBD and hemp-based products company, reported...

VRUS : 0.0001 (unch)
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Verus International, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the District of Maryland...

VRUS : 0.0001 (unch)
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verus International, Inc. Investors With Losses Over $100K to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – VRUS

WHY: NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Verus International, Inc. (OTC: VRUS) between June 17, 2019...

VRUS : 0.0001 (unch)
ROSEN, A TOP RANKED LAW FIRM, Encourages Verus International, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important June 22 Deadline in Securities Class Action – VRUS

NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Verus International, Inc. (OTC: VRUS) between June 17, 2019...

VRUS : 0.0001 (unch)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Verus and Frequency, and Encourages Investors to Contact the Firm

NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders...

VRUS : 0.0001 (unch)
FREQ : 14.9800 (+5.94%)
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Verus International, Inc. Investors to Secure Counsel Before Important June 22 Deadline in Securities Class Action – VRUS

WHY: NEW YORK, June 05, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Verus International, Inc. (OTC: VRUS) between June 17, 2019...

VRUS : 0.0001 (unch)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Churchill, Emergent BioSolutions, and Verus International and Encourages Investors to Contact the Firm

NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders...

FUV : 0.3800 (-5.00%)
CCIV : 24.25 (+5.90%)
EBS : 8.06 (-0.49%)
VRUS : 0.0001 (unch)

Business Summary

Pharmasset, Inc. was incorporated under the laws of Delaware on June 8, 2004. It is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. The Company's primary focus is on the development of nucleoside/tide analogs as...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point N/A
1st Resistance Point N/A
Last Price 0.0001
1st Support Level N/A
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 0.0001
Fibonacci 61.8% 0.0001
Fibonacci 50% 0.0001
Fibonacci 38.2% 0.0001
Last Price 0.0001
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar